Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia. (Q43744300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

0 references

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Laura Rowland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

J R Bustillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Lauriello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R E Jung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

H Petropoulos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

B L Hart

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Blanchard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S J Keith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

135-149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

A rating scale for drug-induced akathisia

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

The effects of haloperidol on synaptic patterns in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Reproducibility of 1H-MRS in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Neuroleptic medications inhibit complex I of the electron transport chain.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Schizophrenia: improving outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

The action of chlorpromazine and imipramine on rat brain mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Biochemical and behavioural properties of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Decreased left frontal lobe N-acetylaspartate in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Conventional antipsychotic medications for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Heritability heightens brain metabolite differences in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

The effect of chronic haloperidol treatment on dendritic spines in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Changes in caudate volume with neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Method to correlate 1H MRSI and 18FDG-PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Automated T2 quantitation in neuropsychiatric lupus erythematosus: a marker of active disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Childhood-onset schizophrenia. Progressive ventricular change during adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Time and frequency domain analysis of NMR data compared: an application to 1D 1H spectra of lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

The effects of early and sustained intervention on the long-term morbidity of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900102-0

7 January 2021

10.1016/S0925-4927(01)00102-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11566430%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference